PAVmed (PAVM) Acquisitions (2021 - 2022)

PAVmed (PAVM) recorded quarterly Acquisitions of $1.0 million in Q3 2022, down 52.38% quarter-over-quarter from $2.1 million in Q4 2021, and up 900.0% on a YoY basis from $100000.0 in Q3 2021.

PAVmed (PAVM) Acquisitions (2021 - 2022) Analysis & Trends

PAVmed's Acquisitions history runs 2 years deep, the most recent figure standing at $1.0 million for Q3 2022.

  • In Q3 2022, Acquisitions rose 900.0% year-over-year to $1.0 million; the TTM figure through Dec 2022 stood at $3.2 million (changed N/A YoY), while the FY2022 annual figure was $3.2 million, up 42.41% from the prior year.
  • Acquisitions was $1.0 million for Q3 2022 at PAVmed, down from $2.1 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $2.1 million in Q4 2021 to a low of $100000.0 in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Acquisitions (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 22.00 Mn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 523.00 Mn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -268.10 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 2.30 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 PAVmed 2.70 Mn -10.47 Mn -703,000.00 -

Historic Data

Download Data
DateValue
Sep 30, 2022 1.00 Mn
Dec 31, 2021 2.10 Mn
Sep 30, 2021 100,000.00